NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract Taurine, a semi-essential amino acid, declines by 80% in mice and monkeys with aging. Taurine has therapeutic effects ranging from treatment of depression, Alzheimer’s and Parkinson’s disease, obesity, diabetes, neuroendocrine function, osteoarthritis, neurodegeneration and aging. TRH and TRH-like peptides, with the structure pGlu-X-Pro-NH 2 , where “X” can be any amino acid reside, have reproductive, caloric-restriction-like, anti-aging, pancreatic-β cell-enhancing, cardiovascular, and neuroprotective effects. Sixteen young adult male Sprague-Dawley rats were divided into 4 groups. Control group remained on ad libitum chow and water for 10 days. Acute group received ad libitum chow and water for 9 days and then 2.5% taurine in rat chow for 24 h. Chronic animals received taurine in chow for 10 days. Withdrawal rats received taurine chow for 8 days and then normal chow for 2 days. TRH and TRH-like peptide levels were measured in 12 brain regions and 7 peripheral tissues. Significant changes in the levels of TRH and TRH-like peptides occurred throughout the brain and peripheral tissues in response to taurine treatment. The sensitivity of TRH and TRH-like peptide expression to taurine treatment, particularly in the cerebellum, frontal cortex, amygdala and hippocampus, liver, epididymis and pancreas is consistent with TRH and TRH-like peptides participating in the therapeutic effects of taurine on neurological, reproductive, and metabolic disorders.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.